Mylan N.V. (MYL) Cut to Hold at ValuEngine

ValuEngine cut shares of Mylan N.V. (NASDAQ:MYL) from a buy rating to a hold rating in a report issued on Wednesday.

MYL has been the topic of several other reports. Cowen and Company restated a market perform rating and set a $43.00 price target (down from $55.00) on shares of Mylan N.V. in a research note on Sunday, May 21st. Zacks Investment Research lowered Mylan N.V. from a hold rating to a sell rating in a research note on Monday, May 15th. Guggenheim restated a neutral rating on shares of Mylan N.V. in a research note on Friday, March 3rd. Vetr lowered Mylan N.V. from a strong-buy rating to a buy rating and set a $44.68 price target on the stock. in a research note on Tuesday, February 14th. Finally, Leerink Swann restated an outperform rating and set a $52.00 price target on shares of Mylan N.V. in a research note on Monday, March 6th. Two analysts have rated the stock with a sell rating, eleven have issued a hold rating, eleven have given a buy rating and two have assigned a strong buy rating to the stock. The company has an average rating of Buy and an average price target of $50.77.

Analyst Recommendations for Mylan N.V. (NASDAQ:MYL)

Mylan N.V. (NASDAQ MYL) opened at 37.23 on Wednesday. Mylan N.V. has a 52 week low of $33.60 and a 52 week high of $50.40. The company has a market capitalization of $19.95 billion, a price-to-earnings ratio of 37.19 and a beta of 1.23. The company has a 50 day moving average of $38.54 and a 200 day moving average of $39.04.

Mylan N.V. (NASDAQ:MYL) last issued its quarterly earnings results on Wednesday, May 10th. The company reported $0.93 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.92 by $0.01. Mylan N.V. had a return on equity of 23.69% and a net margin of 4.59%. The firm had revenue of $2.72 billion for the quarter, compared to analyst estimates of $2.81 billion. During the same period in the previous year, the company posted $0.76 earnings per share. The company’s quarterly revenue was up 24.1% compared to the same quarter last year. On average, equities analysts forecast that Mylan N.V. will post $5.19 EPS for the current fiscal year.

COPYRIGHT VIOLATION NOTICE: “Mylan N.V. (MYL) Cut to Hold at ValuEngine” was reported by Ticker Report and is the sole property of of Ticker Report. If you are reading this story on another website, it was illegally stolen and republished in violation of US and international trademark & copyright laws. The correct version of this story can be read at https://www.tickerreport.com/banking-finance/2654850/mylan-n-v-myl-cut-to-hold-at-valuengine.html.

In other Mylan N.V. news, President Rajiv Malik sold 25,000 shares of the company’s stock in a transaction on Friday, June 9th. The stock was sold at an average price of $40.00, for a total transaction of $1,000,000.00. Following the transaction, the president now owns 799,855 shares of the company’s stock, valued at approximately $31,994,200. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Also, major shareholder Laboratories Abbott sold 44,000,000 shares of the company’s stock in a transaction on Thursday, March 23rd. The stock was sold at an average price of $41.60, for a total value of $1,830,400,000.00. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 44,035,000 shares of company stock worth $1,831,800,000. Company insiders own 0.69% of the company’s stock.

Hedge funds have recently modified their holdings of the stock. Wellington Management Group LLP boosted its stake in shares of Mylan N.V. by 2.6% in the first quarter. Wellington Management Group LLP now owns 46,373,108 shares of the company’s stock valued at $1,808,088,000 after buying an additional 1,165,852 shares during the last quarter. BlackRock Inc. boosted its stake in shares of Mylan N.V. by 3,447.5% in the first quarter. BlackRock Inc. now owns 38,822,643 shares of the company’s stock valued at $1,513,696,000 after buying an additional 37,728,274 shares during the last quarter. Vanguard Group Inc. boosted its stake in shares of Mylan N.V. by 3.9% in the first quarter. Vanguard Group Inc. now owns 29,348,816 shares of the company’s stock valued at $1,144,310,000 after buying an additional 1,090,791 shares during the last quarter. State Street Corp boosted its stake in shares of Mylan N.V. by 1.2% in the first quarter. State Street Corp now owns 20,176,564 shares of the company’s stock valued at $786,700,000 after buying an additional 234,521 shares during the last quarter. Finally, Pzena Investment Management LLC acquired a new stake in shares of Mylan N.V. during the first quarter valued at approximately $283,158,000. Institutional investors own 69.89% of the company’s stock.

About Mylan N.V.

Mylan N.V. is a global pharmaceutical company. The Company develops, licenses, manufactures, markets and distributes generic and branded generic products for resale by others; specialty pharmaceuticals, and active pharmaceutical ingredients (APIs). It operates through two segments: Generics and Specialty.

To view ValuEngine’s full report, visit ValuEngine’s official website.

Receive News & Ratings for Mylan N.V. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mylan N.V. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Super Nintendo World Theme Park Officially Starts Construction
Super Nintendo World Theme Park Officially Starts Construction
Amazon and Apple Join Foxconn to Secure Chip Business of Toshiba
Amazon and Apple Join Foxconn to Secure Chip Business of Toshiba
Camera Zooms In and Can Recognize Faces
Camera Zooms In and Can Recognize Faces
Netflix Could See 150 Million Worldwide Subscribers
Netflix Could See 150 Million Worldwide Subscribers
LeEco Cutting Over 70% of Staff in U.S. Amidst Pull Back
LeEco Cutting Over 70% of Staff in U.S. Amidst Pull Back
Shares at Radius Jump as Bone Drug of Amgen Has Setback
Shares at Radius Jump as Bone Drug of Amgen Has Setback


© 2006-2017 Ticker Report. Google+.